Free Trial

OVERSEA CHINESE BANKING Corp Ltd Purchases Shares of 2,506 The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background

Key Points

  • Oversea Chinese Banking Corp Ltd has purchased a new stake in The Clorox Company, acquiring 2,506 shares valued at approximately $369,000 in the 1st quarter.
  • Analyst ratings on Clorox have varied, with Wells Fargo increasing their price target to $138.00, while Barclays lowered theirs to $119.00, reflecting differing outlooks on the company's stock.
  • The Clorox Company reported financial growth, with a 4.5% year-over-year increase in revenue, and will increase its quarterly dividend from $1.22 to $1.24 per share.
  • Need better tools to track Clorox? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

OVERSEA CHINESE BANKING Corp Ltd acquired a new stake in The Clorox Company (NYSE:CLX - Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 2,506 shares of the company's stock, valued at approximately $369,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. Sonora Investment Management Group LLC increased its position in Clorox by 2.5% during the first quarter. Sonora Investment Management Group LLC now owns 2,940 shares of the company's stock valued at $433,000 after acquiring an additional 72 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in shares of Clorox by 0.6% in the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company's stock worth $1,953,000 after buying an additional 73 shares in the last quarter. Wedbush Securities Inc. grew its position in shares of Clorox by 1.2% during the fourth quarter. Wedbush Securities Inc. now owns 7,624 shares of the company's stock valued at $1,238,000 after purchasing an additional 94 shares in the last quarter. Financial Avengers Inc. increased its holdings in shares of Clorox by 32.1% in the 4th quarter. Financial Avengers Inc. now owns 457 shares of the company's stock worth $74,000 after buying an additional 111 shares during the last quarter. Finally, ABLE Financial Group LLC lifted its stake in shares of Clorox by 3.3% in the 4th quarter. ABLE Financial Group LLC now owns 3,502 shares of the company's stock valued at $569,000 after purchasing an additional 113 shares during the last quarter. Institutional investors own 78.53% of the company's stock.

Clorox Trading Down 0.9%

NYSE:CLX traded down $1.14 during mid-day trading on Friday, reaching $124.94. 916,340 shares of the company's stock traded hands, compared to its average volume of 1,634,686. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The Clorox Company has a 12-month low of $117.35 and a 12-month high of $171.37. The firm has a market capitalization of $15.40 billion, a price-to-earnings ratio of 19.16, a PEG ratio of 1.00 and a beta of 0.49. The company has a 50 day moving average price of $125.65 and a 200-day moving average price of $138.19.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analysts' expectations of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. Clorox's revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.82 EPS. On average, sell-side analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th will be paid a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, August 13th. This is a positive change from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 annualized dividend and a yield of 4.0%. Clorox's payout ratio is presently 74.85%.

Analyst Ratings Changes

A number of research analysts have commented on CLX shares. Evercore ISI set a $140.00 price target on Clorox and gave the stock an "underperform" rating in a research note on Tuesday, May 6th. Citigroup reissued a "neutral" rating and issued a $135.00 target price (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Jefferies Financial Group dropped their price target on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. JPMorgan Chase & Co. dropped their price objective on shares of Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Finally, UBS Group lowered their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a report on Thursday, July 17th. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Clorox presently has a consensus rating of "Hold" and an average target price of $143.36.

Get Our Latest Stock Analysis on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: All Signs Point to More Growth Ahead
3 Quiet Growth Stocks With Major Momentum
The Market’s Next Big Winners? Start Here

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines